BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 20509834)

  • 1. Minor histocompatibility antigen HA-1 and HA-2 polymorphisms in Taiwan: frequency and application in hematopoietic stem cell transplantation.
    Lio HY; Tang JL; Wu J; Wu SJ; Lin CY; Yang YC
    Clin Chem Lab Med; 2010 Sep; 48(9):1287-93. PubMed ID: 20509834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does minor histocompatibility antigen HA-1 disparity affect the occurrence of graft-versus-host disease in tunisian recipients of hematopoietic stem cells?
    Sellami MH; Torjemane L; Arias AE; Kaabi H; Ladeb S; Poli F; Othmane TB; Hmida S
    Clinics (Sao Paulo); 2010; 65(11):1099-103. PubMed ID: 21243279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of donor KIRs and recipient KIR/HLA class I combinations on GVHD in patients with acute leukemia after HLA-matched sibling HSCT.
    Mansouri M; Villard J; Ramzi M; Alavianmehr A; Farjadian S
    Hum Immunol; 2020 Jun; 81(6):285-292. PubMed ID: 32199702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation.
    Spierings E; Kim YH; Hendriks M; Borst E; Sergeant R; Canossi A; Oudshoorn M; Loiseau P; Dolstra H; Markiewicz M; Leffell MS; Pereira N; Kircher B; Turpeinen H; Eliaou JF; Gervais T; Laurin D; Enczmann J; Martinetti M; Thomson J; Oguz F; Santarone S; Partanen J; Siekiera U; Alessandrino EP; Kalayoglu S; Brand R; Goulmy E
    Biol Blood Marrow Transplant; 2013 Aug; 19(8):1244-53. PubMed ID: 23756210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations.
    Di Terlizzi S; Zino E; Mazzi B; Magnani C; Tresoldi C; Perna SK; Bregni M; Rossini S; Ciceri F; Bordignon C; Bonini C; Fleischhauer K
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):95-101. PubMed ID: 16399573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenic disparities of 11 minor histocompatibility antigens (mHAs) in HLA-matched unrelated allogeneic hematopoietic SCT.
    Markiewicz M; Siekiera U; Karolczyk A; Szymszal J; Helbig G; Wojnar J; Dzierzak-Mietla M; Kyrcz-Krzemien S
    Bone Marrow Transplant; 2009 Feb; 43(4):293-300. PubMed ID: 18850018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
    Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
    Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of disparity of minor histocompatibility antigens HA-1, CD31, and CD49b in hematopoietic stem cell transplantation of patients with chronic myeloid leukemia with sibling and unrelated donors.
    Heinemann FM; Ferencik S; Ottinger HD; Beelen DW; Grosse-Wilde H
    Transplantation; 2004 Apr; 77(7):1103-6. PubMed ID: 15087780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Minor histocompatibility antigens as determinants for graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
    Turpeinen H; Ojala PJ; Ojala K; Miettinen M; Volin L; Partanen J
    Int J Immunogenet; 2013 Dec; 40(6):495-501. PubMed ID: 23480177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of the minor histocompatibility antigens in Korean population and disparities in unrelated hematopoietic SCT.
    Park MJ; Choi HB; Jang JP; Kim HJ; Kim YJ; Eom KS; Lee S; Kim DW; Lee JW; Min WS; Kim CC; Kim TG
    Bone Marrow Transplant; 2007 Oct; 40(8):723-8. PubMed ID: 17700601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between disparity for the minor histocompatibility antigen HA-1 and the development of acute graft-versus-host disease after allogeneic marrow transplantation.
    Tseng LH; Lin MT; Hansen JA; Gooley T; Pei J; Smith AG; Martin EG; Petersdorf EW; Martin PJ
    Blood; 1999 Oct; 94(8):2911-4. PubMed ID: 10515896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Frequencies of 10 autosomal minor histocompatibility antigens in Korean population and estimated disparities in unrelated hematopoietic stem cell transplantation.
    Jung H; Ki CS; Kim JW; Kang ES
    Tissue Antigens; 2012 Jan; 79(1):42-9. PubMed ID: 22150369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide surveillance of mismatched alleles for graft-versus-host disease in stem cell transplantation.
    Sato-Otsubo A; Nannya Y; Kashiwase K; Onizuka M; Azuma F; Akatsuka Y; Ogino Y; Satake M; Sanada M; Chiba S; Saji H; Inoko H; Kennedy GC; Yamamoto K; Morishima S; Morishima Y; Kodera Y; Sasazuki T; Ogawa S;
    Blood; 2015 Dec; 126(25):2752-63. PubMed ID: 26432889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both genetic and clinical factors predict the development of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Socié G; Loiseau P; Tamouza R; Janin A; Busson M; Gluckman E; Charron D
    Transplantation; 2001 Aug; 72(4):699-706. PubMed ID: 11544434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LMP7 polymorphism may modify the presentation and clinical impact of minor histocompatibility antigens in matched related hematopoietic stem cell transplantation.
    Mossallam GI; Fattah RA; Bokhary M; Moneer M; Mahmoud HK
    Cell Immunol; 2021 Jun; 364():104329. PubMed ID: 33798908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Definition of the gene encoding the minor histocompatibility antigen HA-1 and typing for HA-1 from genomic DNA.
    Tseng LH; Lin MT; Martin PJ; Pei J; Smith AG; Hansen JA
    Tissue Antigens; 1998 Oct; 52(4):305-11. PubMed ID: 9820595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of CD31 mismatches on the outcome of hematopoeitic stem cell transplant of HLA-identical sibling.
    El-Chennawi FA; Kamel HA; Mosaad YM; El-Sherbini SM; El-Billey NA
    Hematology; 2006 Aug; 11(4):227-34. PubMed ID: 17178660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of mismatching for minor histocompatibility antigens on clinical outcomes in HLA-matched, unrelated hematopoietic stem cell transplants.
    Spellman S; Warden MB; Haagenson M; Pietz BC; Goulmy E; Warren EH; Wang T; Ellis TM
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):856-63. PubMed ID: 19539218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of polymorphic MHC microsatellites with GVHD, survival, and leukemia relapse in unrelated hematopoietic stem cell transplant donor/recipient pairs matched at five HLA loci.
    Li S; Kawata H; Katsuyama Y; Ota M; Morishima Y; Mano S; Kulski JK; Naruse T; Inoko H
    Tissue Antigens; 2004 Apr; 63(4):362-8. PubMed ID: 15009808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Computational Analysis of HLA-presentation of Non-synonymous Recipient Mismatches Indicates Effect on the Risk of Chronic Graft-vs.-Host Disease After Allogeneic HSCT.
    Ritari J; Hyvärinen K; Koskela S; Niittyvuopio R; Nihtinen A; Salmenniemi U; Putkonen M; Volin L; Kwan T; Pastinen T; Itälä-Remes M; Partanen J
    Front Immunol; 2019; 10():1625. PubMed ID: 31379830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.